Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT06583460
Eligibility Criteria:
Inclusion Criteria:
* Women ≥ 18 years (menopausal or not),
* Localized breast cancer with or without lymph node involvement,
* Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
* Patient affiliated or benefiting from the social security system,
* Patient informed and informed consent signed.
Exclusion Criteria:
* History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
* Pregnant or breast-feeding women,
* Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
* Patients unable to comply with the study schedule for social, medical or psychological reasons.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06583460
Study Brief:
Protocol Section:
NCT06583460